Last updated 2026-08-22
Total raised
—
Stage
—
Founded
2026
Headcount
—
HQ
Tel Aviv, Israel
Sector
Medical Devices
About
Quintra Medical is developing the first substrate modifying technology that targets the root biochemical and electrical drivers of Sudden Cardiac Death (SCD), offering patients a path to freedom from lifelong device dependency. Their groundbreaking technology aims to provide a curative approach rather than symptomatic management.
Q&A
- What is Quintra Medical's primary focus?
- Quintra Medical is pioneering a revolutionary therapeutic approach to neutralize the silent drivers of sudden cardiac death risk in Brugada Syndrome patients.
- What problem does Quintra Medical aim to solve?
- Quintra Medical is developing the first substrate modifying technology that targets the root biochemical and electrical drivers of Sudden Cardiac Death (SCD), aiming to free patients from lifelong device dependency.
- Where is Quintra Medical headquartered?
- Quintra Medical is headquartered in Tel Aviv, Israel.
- When was Quintra Medical founded?
- Quintra Medical was founded in 2026.
- Who is the CEO of Quintra Medical?
- Eyal Sandach is the CEO of Quintra Medical.
- What is Quintra Medical's primary sector?
- Quintra Medical's primary sector is Medical Devices.
- What is the legal name of Quintra Medical?
- The legal name of the company is QUINTRA MEDICAL LTD.
Team · 1
Eyal Sandach
CEO
Sectors & technology
Primary sector
Medical Devices
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | quintramedical.com |
|---|
Identifiers & details
| Legal name | QUINTRA MEDICAL LTD |
|---|---|
| Founded | 2026 |